Breakthrough CAR-T Therapy Shows Promising Outcomes in Patients with Refractory Lymphoma
A groundbreaking advancement in the fight against refractory CD30-positive lymphomas has emerged from researchers at the Sant Pau Research Institute (IR Sant Pau), in conjunction...